OmnicellOMCL
About: Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.
Employees: 3,590
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
1,039% more call options, than puts
Call options by funds: $38.5M | Put options by funds: $3.38M
70% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 30
44% more repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 73
7% more funds holding
Funds holding: 258 [Q3] → 276 (+18) [Q4]
3% more capital invested
Capital invested by funds: $2B [Q3] → $2.06B (+$53.8M) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]
0.28% less ownership
Funds ownership: 100.09% [Q3] → 99.81% (-0.28%) [Q4]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Benchmark Bill Sutherland 45% 1-year accuracy 20 / 44 met price target | 74%upside $62 | Buy Maintained | 4 Feb 2025 |
Wells Fargo Stan Berenshteyn 30% 1-year accuracy 3 / 10 met price target | 12%upside $40 | Equal-Weight Maintained | 13 Jan 2025 |
B of A Securities Allen Lutz 80% 1-year accuracy 12 / 15 met price target | 29%upside $46 | Neutral Maintained | 6 Jan 2025 |
Financial journalist opinion
Based on 6 articles about OMCL published over the past 30 days
